Search details
1.
Romosozumab in patients who experienced an on-study fracture: post hoc analyses of the FRAME and ARCH phase 3 trials.
Osteoporos Int
; 2024 Apr 04.
Article
in English
| MEDLINE | ID: mdl-38573517
2.
Comparative effectiveness and cardiovascular safety of abaloparatide and teriparatide in postmenopausal women new to anabolic therapy: A US administrative claims database study.
Osteoporos Int
; 33(8): 1703-1714, 2022 Aug.
Article
in English
| MEDLINE | ID: mdl-35524068
3.
Teriparatide and pelvic fracture healing: a phase 2 randomized controlled trial.
Osteoporos Int
; 33(1): 239-250, 2022 Jan.
Article
in English
| MEDLINE | ID: mdl-34383100
4.
Early changes in bone turnover and bone mineral density after discontinuation of long-term oral bisphosphonates: a post hoc analysis.
Osteoporos Int
; 32(9): 1879-1888, 2021 Sep.
Article
in English
| MEDLINE | ID: mdl-33606045
5.
Vertebral fracture assessment (VFA) for osteoporosis screening in US postmenopausal women: is it cost-effective?
Osteoporos Int
; 31(12): 2321-2335, 2020 Dec.
Article
in English
| MEDLINE | ID: mdl-32778935
6.
Correction to: Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis.
Osteoporos Int
; 31(8): 1603-1605, 2020 Aug.
Article
in English
| MEDLINE | ID: mdl-32533195
7.
Correction to: Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis.
Osteoporos Int
; 31(5): 1017-1018, 2020 May.
Article
in English
| MEDLINE | ID: mdl-32232508
8.
Biomechanical Computed Tomography analysis (BCT) for clinical assessment of osteoporosis.
Osteoporos Int
; 31(6): 1025-1048, 2020 Jun.
Article
in English
| MEDLINE | ID: mdl-32335687
9.
Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis.
Osteoporos Int
; 30(6): 1187-1194, 2019 Jun.
Article
in English
| MEDLINE | ID: mdl-30899994
10.
Spine fracture prevalence in a nationally representative sample of US women and men aged ≥40 years: results from the National Health and Nutrition Examination Survey (NHANES) 2013-2014---supplementary presentation.
Osteoporos Int
; 28(8): 2319-2320, 2017 08.
Article
in English
| MEDLINE | ID: mdl-28695242
11.
Spine fracture prevalence in a nationally representative sample of US women and men aged ≥40 years: results from the National Health and Nutrition Examination Survey (NHANES) 2013-2014.
Osteoporos Int
; 28(6): 1857-1866, 2017 06.
Article
in English
| MEDLINE | ID: mdl-28175980
12.
A phase 2 study of MK-5442, a calcium-sensing receptor antagonist, in postmenopausal women with osteoporosis after long-term use of oral bisphosphonates.
Osteoporos Int
; 27(1): 377-86, 2016 Jan.
Article
in English
| MEDLINE | ID: mdl-26556736
13.
Clinician's Guide to Prevention and Treatment of Osteoporosis.
Osteoporos Int
; 25(10): 2359-81, 2014 Oct.
Article
in English
| MEDLINE | ID: mdl-25182228
14.
Unmasking romosozumab: response to commentsby Uzoigwe et al.
Osteoporos Int
; 28(6): 2021-2022, 2017 06.
Article
in English
| MEDLINE | ID: mdl-28213618
15.
Skeletal effects of vitamin D supplementation in postmenopausal black women.
Calcif Tissue Int
; 91(5): 316-24, 2012 Nov.
Article
in English
| MEDLINE | ID: mdl-22923289
16.
Erratum to: Clinician's guide to prevention and treatment of osteoporosis.
Osteoporos Int
; 26(7): 2045-7, 2015 Jul.
Article
in English
| MEDLINE | ID: mdl-25986381
17.
Fragility fractures of the hip and femur: incidence and patient characteristics.
Osteoporos Int
; 21(3): 399-408, 2010 Mar.
Article
in English
| MEDLINE | ID: mdl-19484169
18.
DXA-based hip structural analysis of once-weekly bisphosphonate-treated postmenopausal women with low bone mass.
Osteoporos Int
; 20(6): 911-21, 2009 Jun.
Article
in English
| MEDLINE | ID: mdl-18830555
19.
Relationship Between Bone Mineral Density T-Score and Nonvertebral Fracture Risk Over 10 Years of Denosumab Treatment.
J Bone Miner Res
; 34(6): 1033-1040, 2019 06.
Article
in English
| MEDLINE | ID: mdl-30919997
20.
Relationship between growth hormone in vivo bioactivity, the insulin-like growth factor-I system and bone mineral density in young, physically fit men and women.
Growth Horm IGF Res
; 18(5): 439-445, 2008 Oct.
Article
in English
| MEDLINE | ID: mdl-18482854